Involvement of endogenous prostaglandin F2α on kainic acid-induced seizure activity through FP receptor:: The mechanism of proconvulsant effects of COX-2 inhibitors

被引:65
作者
Kim, Hee-Jae [1 ,2 ,3 ]
Chung, Jee-In [1 ,2 ,3 ]
Lee, Soo Hwan [1 ,3 ]
Jung, Yi-Sook [1 ]
Moon, Chang-Hyun [1 ,3 ]
Baik, Eun Joo [1 ,2 ,3 ]
机构
[1] Ajou Univ, Sch Med, Dept Physiol, Suwon 443749, South Korea
[2] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 443749, South Korea
[3] Ajou Univ, Sch Med, Neurosci Grad Program BK21, Suwon 443749, South Korea
关键词
seizure; prostaglandin F-2 alpha (PGF(2 alpha)); COX-2; inhibitor; NSAID;
D O I
10.1016/j.brainres.2007.12.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
COX-2 and prostaglandins (PGs) might play important roles in epilepsy. In kainic acid-induced seizures, the brain largely increases PGD(2), first from COX-1 and later COX-2-induced PGF(2 alpha). Pre-treatment with COX-2 inhibitors such as indomethacin, nimesulide, and celecoxib is known to aggravate kainic acid (KA)-induced seizure activity. However it is not known whether the proconvulsant effect of those non-steroidal anti-inflammatory drugs (NSAIDs) is due to changes in endogenous prostaglandins (PGs), or what types of PGs are involved. The purpose of this study was to determine the effect of intracisternally administered PGs on KA-induced seizures aggravated by pre- or post-treatment with COX-2 inhibitors. Systemic KA injection (10 mg/kg i.p.) in mice evoked mild seizure activity within 15 min. PGs were administrated intracisternally 20 min prior to KA administration. COX inhibitors (indomethacin, nimesulide, and ketoprofen, 10 mg/kg i.p.) were injected I h before or 15 min after KA. An additional COX-2 inhibitor, celecoxib, was administered orally. Intracisternally administered PGF(2 alpha). (700 ng), but not PGD(2) (700 ng) or PGE(2) (700 ng) completely alleviated KA-induced seizures potentiated by COX-2 inhibitors, and also reduced KA-induced hippocampal neuronal death aggravated by indomethacin. PGF(2 alpha) alone did not affect KA-induced seizures. However, an FP receptor antagonist, AL 8810 (10 or 50 ng) which is an 11 beta-fluoro analogue of PGF(2 alpha) potentiated KA-induced seizure activity dose-dependently. In summary, pre- or post-treatment with COX-2 inhibitors aggravates KA-induced seizures, which suggests to change the endogenous PGF(2 alpha). Seizure-induced PGF(2 alpha). might act as an endogenous anticonvulsant through FP receptors. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 39 条
[1]   Prostaglandin E2 and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity:: No impact on survival of seizure-generated neurons [J].
Ajmone-Cat, Maria Antonietta ;
Iosif, Robert E. ;
Ekdahl, Christine T. ;
Kokaia, Zaal ;
Minghetti, Luisa ;
Lindvall, Olle .
NEUROBIOLOGY OF DISEASE, 2006, 23 (01) :23-35
[2]  
Akarsu ES, 1998, EPILEPSY RES, V30, P63
[3]  
ARMY JJ, 1975, PROSTAGLANDINS, V10, P395
[4]   Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus [J].
Baik, EJ ;
Kim, EJ ;
Lee, SH ;
Moon, CH .
BRAIN RESEARCH, 1999, 843 (1-2) :118-129
[5]   INCREASED PROSTAGLANDIN FORMATION IN RAT-BRAIN FOLLOWING SYSTEMIC APPLICATION OF KAINIC ACID [J].
BARAN, H ;
HELDT, R ;
HERTTING, G .
BRAIN RESEARCH, 1987, 404 (1-2) :107-112
[6]   INHIBITION OF PENTYLENETETRAZOL-INDUCED CONVULSIONS IN RATS BY PROSTAGLANDIN-E1 - ROLE OF BRAIN MONO-AMINES [J].
BHATTACHARYA, SK ;
SANYAL, AK .
PSYCHOPHARMACOLOGY, 1978, 56 (02) :235-237
[7]   PROSTAGLANDIN-D2 INHIBITS PENTYLENETETRAZOLE-INDUCED CONVULSIONS IN RATS BY A SEROTONIN-MEDIATED MECHANISM [J].
BHATTACHARYA, SK ;
PARMAR, SS .
PHARMACEUTICAL RESEARCH, 1987, 4 (05) :406-408
[8]   Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats [J].
Browne, Kevin D. ;
Iwata, Akira ;
Putt, M. E. ;
Smith, Douglas H. .
EXPERIMENTAL NEUROLOGY, 2006, 201 (02) :301-307
[9]   Pharmacology of celecoxib in rat brain after kainate administration [J].
Ciceri, P ;
Zhang, Y ;
Shaffer, AF ;
Leahy, KM ;
Woerner, MB ;
Smith, WG ;
Seibert, K ;
Isakson, PC .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (03) :846-852
[10]  
CLIMAX J, 1981, ARCH INT PHARMACOD T, V250, P254